Stopping statins after stroke raises risk of death, dependencyAugust 28, 2007ST. PAUL, MN- People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the August 28, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology. The study found that people who stopped taking their cholesterol-lowering drugs, also called statins, while hospitalized after a stroke were 4.7 times more likely to have died or be dependent on others for their care three months after the stroke than people who kept taking the drugs. "These results strongly support the recommendation to physicians to continue statin drugs during the acute phase of an ischemic stroke," said study author José Castillo, MD, PhD, of the University of Santiago de Compostela in Santiago de Compostela, Spain.
Castillo said that while no protocols suggest that patients should not receive statins after a stroke, in many cases the drugs are discontinued to avoid problems that can occur when stomach content is regurgitated into the lungs. "This study clearly shows the benefits of continuing statin use," he said. The study involved 89 people who were already taking the cholesterol-lowering drugs at the time when they had a stroke. For the first three days after being admitted to the hospital, 46 of the people received no statin drugs and 43 received the drugs. After three months, 27 people, or 60 percent, of the group that received no statins had either died or were disabled to the point that they could not complete their daily activities independently, compared to 16 people, or 39 percent, of the group that kept taking statins. Previous studies have shown that people who are taking statins at the time of a stroke have less severe strokes than those who aren't taking statins. Statins appear to do more than reduce cholesterol. They also reduce inflammation and help keep the blood from clotting, which can cause stroke. Statins also increase the release of nitric oxide, which is protective, from the cells lining artery walls. American Academy of Neurology | |||||||||||||||||||||
|
Related Stroke News Articles Bisphenol A linked to metabolic syndrome in human tissue New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences. Obese people with asthma have nearly 5 times greater risk of hospitalization for asthma Obese people who have asthma are nearly five times more likely to be hospitalized for the condition than non-obese people with asthma, according to a Kaiser Permanente study published in the September issue of the Journal of Allergy and Clinical Immunology. Safety of antithrombotic treatment in acute coronary syndromes The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion. Gene is likely cause of stroke-inducing vascular malformations UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke. More daytime sleeping predicts less recovery during rehabilitation for older adults A study in the Sept. 1 issue of the journal Sleep shows that daytime sleeping during a rehabilitation stay predicts less functional recovery for older adults, with effects lasting as long as three months. Study shows heavy snoring is an independent risk factor for carotid atherosclerosis A study in the Sept. 1 issue of the journal Sleep shows that objectively measured heavy snoring is an independent risk factor for early carotid atherosclerosis, which may progress to be associated with stroke. Study finds B-vitamin deficiency may cause vascular cognitive impairment A deficiency of B-vitamins may cause vascular cognitive impairment, according to a new study. Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University used an experimental model to examine the metabolic, cognitive, and microvascular effects of dietary B-vitamin deficiency. Antidepressants need new nerve cells to be effective, researchers find Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. Tiny 3-D ultrasound probe guides catheter procedures An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance. Not all fat is created equal A Temple University study finds fat in obese patients is "sick" when compared to fat in lean patients. More Stroke News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||